{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:53:00Z","timestamp":1785336780488,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijrobp.2017.09.033","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T19:32:11Z","timestamp":1506108731000},"page":"174-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of Chromatin Opening in Heterochromatic Non-Small Cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment"],"prefix":"10.1016","volume":"100","author":[{"given":"Mina","family":"Eriksson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"H\u00e5\u00e5g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Brzozowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9192-5858","authenticated-orcid":false,"given":"Magdalena","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Lisowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Lewensohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Viktorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2023-7454","authenticated-orcid":false,"given":"Lovisa","family":"Lundholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.09.033_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrc3486","article-title":"Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host","volume":"13","author":"Timp","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1139\/O10-113","article-title":"Heterochromatin and the DNA damage response: The need to relax","volume":"89","author":"Cann","year":"2011","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib4","doi-asserted-by":"crossref","first-page":"11844","DOI":"10.3390\/ijms130911844","article-title":"The heterochromatic barrier to DNA double strand break repair: How to get the entry visa","volume":"13","author":"Goodarzi","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib5","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1093\/nar\/gkr230","article-title":"DNA double-strand breaks in heterochromatin elicit fast repair protein recruitment, histone H2AX phosphorylation and relocation to euchromatin","volume":"39","author":"Jakob","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molcel.2008.05.017","article-title":"ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin","volume":"31","author":"Goodarzi","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib7","first-page":"102000","article-title":"Nucleosome compaction facilitates Hp1gamma binding to methylated H3K9","volume":"43","author":"Mishima","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fonc.2013.00235","article-title":"Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer","volume":"3","author":"Huffman","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2008.03.037","article-title":"Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy","volume":"269","author":"Carew","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib10","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/cas.13062","article-title":"Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies","volume":"107","author":"Imai","year":"2016","journal-title":"Cancer Sci"},{"issue":"Suppl. 4","key":"10.1016\/j.ijrobp.2017.09.033_bib11","first-page":"S389","article-title":"Treatment of non-small cell lung cancer (NSCLC)","volume":"5","author":"Zarogoulidis","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib12","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.2011.40.8120","article-title":"Tissue platinum concentration and tumor response in non-small-cell lung cancer","volume":"30","author":"Kim","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5301\/tj.5000347","article-title":"HDAC inhibitors: A new radiosensitizer for non-small-cell lung cancer","volume":"101","author":"Zhu","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.24759","article-title":"Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells","volume":"126","author":"Owonikoko","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/JTO.0b013e318220caff","article-title":"Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation","volume":"6","author":"Seo","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4161\/cbt.8.9.8143","article-title":"Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells","volume":"8","author":"Zhang","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2009.24.9094","article-title":"Carboplatin and paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/CAD.0000000000000282","article-title":"Phase I study evaluating the safety and efficacy of oral panobinostat in combination with radiotherapy or chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer","volume":"26","author":"Takhar","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib19","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: Mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib21","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0905653106","article-title":"Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment","volume":"106","author":"Bertolini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3109\/09553002.2014.905725","article-title":"Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells","volume":"90","author":"Lundholm","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib23","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1038\/cddis.2012.211","article-title":"Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK\/ATM activation and diminished cell cycle arrest","volume":"4","author":"Lundholm","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib24","doi-asserted-by":"crossref","first-page":"e58672","DOI":"10.1371\/journal.pone.0058672","article-title":"Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer","volume":"8","author":"Giudice","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12035-013-8441-7","article-title":"The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells","volume":"48","author":"Nor","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/09553000110070289","article-title":"A cytogenetic analysis of the long-term effect of uranium mining on peripheral lymphocytes using the micronucleus-centromere assay","volume":"77","author":"Kryscio","year":"2001","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01323216","article-title":"Radiation induced chromosome aberrations and the Poisson distribution","volume":"16","author":"Edwards","year":"1979","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.biopha.2014.03.011","article-title":"Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in non-small-cell lung cancer cells","volume":"68","author":"Zhou","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib30","doi-asserted-by":"crossref","first-page":"11298","DOI":"10.1158\/0008-5472.CAN-06-0049","article-title":"Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer","volume":"66","author":"Geng","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5732\/cjc.009.10694","article-title":"Effects of heterochromatin in colorectal cancer stem cells on radiosensitivity","volume":"29","author":"Chen","year":"2010","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib32","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1038\/ncomms11310","article-title":"Dynamic and flexible H3K9ME3 bridging via HP1beta dimerization establishes a plastic state of condensed chromatin","volume":"7","author":"Hiragami-Hamada","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib33","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1007\/s13277-014-2182-8","article-title":"Overexpression of HP1gamma is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1126\/science.1199784","article-title":"Proteome half-life dynamics in living human cells","volume":"331","author":"Eden","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib35","article-title":"Micronucleus assays","volume":"Vol. 5","author":"M\u00fcller","year":"1994"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib36","doi-asserted-by":"crossref","first-page":"e41401","DOI":"10.1371\/journal.pone.0041401","article-title":"Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma","volume":"7","author":"Saini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/srep00584","article-title":"Network biology of tumor stem-like cells identified a regulatory role of CBX5 in lung cancer","volume":"2","author":"Yu","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3344","article-title":"Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer","volume":"12","author":"Sulli","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib39","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/ijo.2014.2550","article-title":"Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells","volume":"45","author":"Gotze","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib40","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.18632\/oncotarget.3536","article-title":"Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment","volume":"6","author":"Kuo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib41","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/cas.12271","article-title":"Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck","volume":"104","author":"Chikamatsu","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/onc.2016.337","article-title":"Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer","volume":"36","author":"Witt","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib43","first-page":"10017","article-title":"The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair","volume":"44","author":"Roos","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cyto.b.20450","article-title":"Kinetics of H2AX phosphorylation after exposure to cisplatin","volume":"76","author":"Olive","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib45","doi-asserted-by":"crossref","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib46","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1158\/1078-0432.CCR-15-2388","article-title":"C-myc modulation and acetylation is a key HDAC inhibitor target in cancer","volume":"23","author":"Nebbioso","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib47","doi-asserted-by":"crossref","first-page":"e75622","DOI":"10.1371\/journal.pone.0075622","article-title":"Chromatin compaction protects genomic DNA from radiation damage","volume":"8","author":"Takata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib48","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00432-014-1689-0","article-title":"Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation","volume":"140","author":"Peiffer","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib49","doi-asserted-by":"crossref","first-page":"e0144320","DOI":"10.1371\/journal.pone.0144320","article-title":"Histone deacetylase inhibitors antagonize distinct pathways to suppress tumorigenesis of embryonal rhabdomyosarcoma","volume":"10","author":"Vleeshouwer-Neumann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00411-014-0532-y","article-title":"Intraclonal recovery of \u201cslow clones\u201d\u2014a manifestation of genomic instability: Are mitochondria the key to an explanation?","volume":"53","author":"Szumiel","year":"2014","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01219336","article-title":"Slow clones, reduced clonogenicity, and intraclonal recovery in X-irradiated L5178Y-S cell cultures","volume":"33","author":"Beer","year":"1994","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10637-010-9503-6","article-title":"Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies","volume":"30","author":"Schneider","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2407-13-148","article-title":"HP1gamma expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy","volume":"13","author":"Slezak","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib54","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ijrobp.2017.09.033_bib55","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617339330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617339330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T19:01:48Z","timestamp":1529521308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617339330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0360301617339330"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.09.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Chromatin Opening in Heterochromatic Non-Small Cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}